Xiuning Le

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  

Xiuning Le
Oct 11, 2024, 17:58 | Insight
Jarushka Naidoo: Randomized Phase II Trial Osimertinib with or without Ramucirumab in 1st line EGFR+NSCLC
Jarushka Naidoo shared a post on X: "RAMOSE: Randomized Ph II Trial Osimertinib+/-Ramucirumab in 1L EGFR+…
Oct 11, 2024, 17:21 | Insight
Xiuning Le: Phase 2 RAMOSE osimertinib with or without ramucrimab in 1L EGFR+ NSCLC
Xiuning Le shared a post on X: "Newly online Journal of Clinical Oncology. Our randomized phase…
Oct 7, 2024, 16:22 | Insight
Xiuning Le: Mutational characteristics and clinical outcomes for EGFR+ lung adenocarcinoma
Xiuning Le, Associate Professor of Thoracic Head and Neck Medical Oncology at the MD Anderson…
Oct 5, 2024, 23:43 | Insight
MD Anderson Research Highlights for the 2024 World Conference on Lung Cancer
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent…
Sep 23, 2024, 13:11 | Blog
Eric K. Singhi: Thrilled to raise awareness and funds for lung cancer research
Eric K. Singhi shared a post on X: ''Thrilled to raise awareness and funds for…
Sep 19, 2024, 15:36 | Blog
Xiuning Le: Busy two weeks WCLC24 and ESMO24
H. Jack West, Vice President of Clinical Development at Summit Therapeutics in Menlo Park, California, shared…
Sep 18, 2024, 09:18 | Insight
34 Posts Not to Miss From ESMO24 Day 4
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 17, 2024, 22:00 | Blog
Xiuning Le: Firmonertinib for EGFR PACC mutations
Xiuning Le shared a post on X by Hidehito Horinouchi adding: "Firmonertinib 240mg for EGFR…
Sep 17, 2024, 16:06 | Blog
Xiuning Le: BAY88 has received USA FDA and Chinese NMPA BTD status for pre-treated HER2-mutant NSCLC
Xiuning Le shared a post by Bayer Oncology on LinkedIn, adding: "BAY88 has received USA FDA and…
Sep 13, 2024, 14:12 | Blog
Xiuning Le: BAY88 in pre-treated HER2-mut NSCLC
Xiuning Le shared  a post by Biagio Ricciuti, on X, adding: "BAY88 in pre-treated HER2-mut…
Sep 11, 2024, 01:59 | Societies
38 Posts Not to Miss From WCLC24 Day 3!
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 10, 2024, 13:18 | Societies
Keeping up with WCLC24 with Eric K. Singhi
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 14:27 | Blog
The Best of WCLC24 Webinar - IASLC
IASLC shared a post on X: “Join us for ‘The Best of World Conference on…
Aug 19, 2024, 08:29 | Insight
4 leading Chinese lung cancer experts to discuss current research/clinical issues, in Mandarin - IASLC
Stephen V. Liu shared a post by IASLC on X, adding: “Thanks to Drs. Chunxia…
Aug 16, 2024, 12:23 | Societies
Hidehito Horinouchi summarizes some abstracts of WCLC24
Hidehito Horinouchi shared on X: Antibody Drug Conjugates in SCLC by Charlie Rudin Ifinatamab Deruxtecan…
Aug 14, 2024, 03:35 | Insight
Hidehito Horinouchi: Presidential 2, WCLC24 abstracts titles
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Aug 14, 2024, 01:53 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 12, 2024, 13:22 | Blog
Xiuning Le: I am honored to have two abstracts in the same Presidential Symposium at WCLC24
Xiuning Le, Associate Professor Thoracic Head and Neck Medical Oncology at MD Anderson Cancer Center,…
Aug 6, 2024, 06:07 | Insight
Primary analysis of the phase 2 INSIGHT 2 study of tepotinib combined with osimertinib
Lungevity Foundation shared a recent article by Yi-Long Wu, commenting: "What's after osimertinib for pts…
Aug 3, 2024, 10:08 | Blog
Xiuning Le: Excited to host Dr. Matthew Oser from DFCI as our GrandRound speaker next week
Xiuning Le, Associate Professor at MD Anderson Cancer Center, shared a post on X: ''I am…
Jul 23, 2024, 00:18 | Blog
Our 9th cohort of Andrew Sabin Family Fellows - MD Anderson Cancer Center
MD Anderson Cancer Center posted on X/Twitter: "Congratulations to our ninth cohort of Andrew Sabin…
Jul 19, 2024, 13:08 | Blog
Xiuning Le: Honored to receive the prestigious Sabin Fellowship
MD Anderson’s Andrew Sabin Family Fellows welcomes 2024 cohort Basic/Translational Scientists Mauro Di Pilato, assistant professor, Immunology…
Jun 15, 2024, 05:08 | Blog
Kelsey Pan: Happy to share our analysis of NSCLC patients with germline EGFR mutations
Kelsey Pan, Heme/Onc Chief Fellow at MD Anderson Cancer Center, shared a post by Stephen V Liu, on…
Apr 29, 2024, 00:06 | Blog
Hear from an expert panel about recent advances in NSCLC - ACCC
Percy Lee, Professor and Vice-Chair of Clinical Research at City of Hope, shared a post…
Apr 5, 2024, 08:01 | Blog
Jordi Remon: In this ASCO Educational Book we summarize EGFR mutated lung cancer
Jordi Remon, Coordinator of the Cancer Medicine Department at CIOCC Barcelona – HM Nou Delfos,…
Mar 25, 2024, 15:15 | Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
All: 26 Posts: 1 - 100
Special Coverage